[PDF][PDF] Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: results of the Australasian Gastrointestinal Trials Group …
Capecitabine, Bevacizumab, and Mitomycin in First-Line Treatment of Metastatic Colorectal
Cancer: Results of the Australasian Ga Page 1 Capecitabine, Bevacizumab, and Mitomycin in …
Cancer: Results of the Australasian Ga Page 1 Capecitabine, Bevacizumab, and Mitomycin in …
[HTML][HTML] Exercise intolerance, benefits, and prescription for people living with a Fontan circulation: the Fontan Fitness Intervention Trial (F-FIT)—rationale and design
DL Tran, H Gibson, AJ Maiorana, CE Verrall… - Frontiers in …, 2022 - frontiersin.org
Background: Despite developments in surgical techniques and medical care, people with a
Fontan circulation still experience long-term complications; non-invasive therapies to …
Fontan circulation still experience long-term complications; non-invasive therapies to …
[HTML][HTML] Estimated glomerular filtration rate and albuminuria are independent predictors of cardiovascular events and death in type 2 diabetes mellitus: the Fenofibrate …
PL Drury, R Ting, D Zannino, C Ehnholm, J Flack… - Diabetologia, 2011 - Springer
Aims/hypothesis We investigated effects of renal function and albuminuria on cardiovascular
outcomes in 9,795 low-risk patients with diabetes in the Fenofibrate Intervention and Event …
outcomes in 9,795 low-risk patients with diabetes in the Fenofibrate Intervention and Event …
[PDF][PDF] Capecitabine versus classical cyclophosphamide, methotrexate, and fluorouracil as first-line chemotherapy for advanced breast cancer
MR Stockler, VJ Harvey, PA Francis, MJ Byrne… - J Clin Oncol, 2011 - academia.edu
Purpose We compared oral capecitabine, administered intermittently or continuously, versus
classical cyclophosphamide, methotrexate, and fluorouracil (CMF) as first-line …
classical cyclophosphamide, methotrexate, and fluorouracil (CMF) as first-line …
Clinical outcomes in adolescents and adults after the Fontan procedure
M Dennis, D Zannino, K du Plessis, A Bullock… - Journal of the American …, 2018 - jacc.org
Background: Long-term outcomes of Fontan patients who survive to age≥ 16 years have
not been well characterized. The Australian and New Zealand Fontan Registry (ANZFR) …
not been well characterized. The Australian and New Zealand Fontan Registry (ANZFR) …
Incidence and predictors of silent myocardial infarction in type 2 diabetes and the effect of fenofibrate: an analysis from the Fenofibrate Intervention and Event …
DC Burgess, D Hunt, LP Li, D Zannino… - European heart …, 2010 - academic.oup.com
Aims To determine the incidence and predictors of, and effects of fenofibrate on silent
myocardial infarction (MI) in a large contemporary cohort of patients with type 2 diabetes in …
myocardial infarction (MI) in a large contemporary cohort of patients with type 2 diabetes in …
Favourable outcomes of 177Lu-octreotate peptide receptor chemoradionuclide therapy in patients with FDG-avid neuroendocrine tumours
Purpose Increased glycolytic activity on FDG PET/CT defines a subgroup of patients with
metastatic gastroenteropancreatic neuroendocrine tumour (NET) with a poor prognosis. A …
metastatic gastroenteropancreatic neuroendocrine tumour (NET) with a poor prognosis. A …
Atrioventricular valve failure in Fontan palliation
G King, J Ayer, D Celermajer, D Zentner, R Justo… - Journal of the American …, 2019 - jacc.org
Background: Atrioventricular valve failure (moderate or greater regurgitation, or valve
operation) is a risk factor for adverse outcomes in patients undergoing Fontan palliation …
operation) is a risk factor for adverse outcomes in patients undergoing Fontan palliation …
[HTML][HTML] Pre-and post-operative determinants of transplantation-free survival after Fontan. The Australia and New Zealand experience
CL Poh, RL Cordina, AJ Iyengar, D Zannino… - IJC Heart & …, 2021 - Elsevier
Background This review identifies the predictors of late mortality and heart transplantation
that remain relevant in the contemporary population of patients with a Fontan circulation …
that remain relevant in the contemporary population of patients with a Fontan circulation …
Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era
S Mantha, DA Goldman, SM Devlin… - Blood, The Journal …, 2017 - ashpublications.org
Acute promyelocytic leukemia (APL) is commonly complicated by a complex coagulopathy.
Uncertainty remains as to which markers of bleeding risk are independent predictors …
Uncertainty remains as to which markers of bleeding risk are independent predictors …